CMRX was down $1.60 after hours Friday. It is still up $15 from the price I bought it when they entered the Ebola fray and it still has good prospects for CMV and adenovirus. I'll sell a little Monday to lock in some profit, but you should consider buying some if it dips enough.
-----------------
CC, good call on buying CMRX in the 20s. I should have joined you in selling some of my TKMR at 29 and buying some CMRX at that time :-). But then I bought more TKMR in the 14-18 range, so it worked out. Although I was cursing myself and Mark Murray until the OnCore merger :-)
The $38.5 price after hours was just on 249 shares. So, it is not a true indication of where it might trade on Monday. Maybe people won't notice next week?
The stock does seem really expensive for a company with no revenues (well not as expensive as ALNY).
I have no problems with how CMRX conducted themselves. I think a lot of us were unhappy with how Tom Frieden at the CDC was pushing / peddling this as the drug of choice. Maybe he and others had a lot of CMRX stock.